Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis.
Pesqué D, Borrego L, Zaragoza-Ninet V, Sanz-Sánchez T, Miquel-Miquel FJ, González-Pérez R, Silvestre JF, Córdoba-Guijarro S, Carrascosa JM, Gatica-Ortega ME, Ruiz-González I, Mercader-García P, Tous-Romero F, Ortiz de Frutos FJ, Serra-Baldrich E, Pastor-Nieto MA, Rodríguez-Serna M, Sánchez-Pérez J, Sánchez-Gilo A, Melé-Ninot G, Sánchez-Pedreño Guillén P, Pujol RM, Giménez-Arnau AM. Pesqué D, et al. Among authors: mele ninot g. J Eur Acad Dermatol Venereol. 2024 Feb 27. doi: 10.1111/jdv.19934. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38411353
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria.
Curto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G, Cubiró X, Bonfill-Ortí M, Garcias-Ladaria J, Villar M, García-Navarro X, Bielsa-Marsol I, Vilavella M, Aparicio G, Baliu-Piqué C, Álvarez A, Lamas-Domenech N, Duran-Jordà X, Serra-Baldrich E, Giménez-Arnau A. Curto-Barredo L, et al. Br J Dermatol. 2018 Jul;179(1):210-212. doi: 10.1111/bjd.16379. Epub 2018 Apr 25. Br J Dermatol. 2018. PMID: 29368377 No abstract available.
Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
Exposito-Serrano V, Curto-Barredo L, Aguilera Peiro P, Gómez Armayones S, Serra-Baldrich E, Spertino J, Bonfill Ortí M, Figueras Nart I, Melé-Ninot G, Baliu-Piqué C, Sala Cunill A, Labrador-Horrillo M, Guilabert Vidal A, Fernández Chico N, Giménez-Arnau AM. Exposito-Serrano V, et al. Br J Dermatol. 2021 Jan;184(1):167-168. doi: 10.1111/bjd.19425. Epub 2020 Sep 2. Br J Dermatol. 2021. PMID: 32730636 No abstract available.
Definition of Recurrent Chronic Spontaneous Urticaria.
Melé-Ninot G, Serra-Baldrich E, Curto-Barredo L, Figueras-Nart I, Spertino J, Expósito-Serrano V, García-Navarro X, Guilabert A, Bielsa-Marsol I, Giménez-Arnau AM. Melé-Ninot G, et al. Acta Derm Venereol. 2020 Sep 23;100(16):adv00267. doi: 10.2340/00015555-3633. Acta Derm Venereol. 2020. PMID: 32926176 Free PMC article. No abstract available.
Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019-2021 epidemiological situation.
Hernández Fernández CP, Borrego L, Mercader García P, Giménez Arnau AM, Sánchez Pérez J, Silvestre Salvador JF, González Pérez R, Sanz Sánchez T, Sánchez Gilo A, Melé Ninot G, Zaragoza Ninet V, Miquel Miquel FJ, Carrascosa Carrillo JM, Córdoba Guijarro S, Gatica Ortega ME, Ruiz González I, Serra Baldrich E, Tous Romero F, Rodríguez Serna M, Pastor Nieto MA, Pérez Feal P, Hervella Garcés M, de Vega Martínez M, García Doval I. Hernández Fernández CP, et al. Contact Dermatitis. 2023 Mar;88(3):212-219. doi: 10.1111/cod.14251. Epub 2022 Dec 1. Contact Dermatitis. 2023. PMID: 36403138
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?
Melé-Ninot G, Serra-Baldrich E, Spertino J, Guilarte M, Ribó González P, Lleonart-Bellfill R, Figueras-Nart I, Bonfill-Ortí M, Depreux N, Sala-Cunill A, Bielsa-Marsol I, Baliu-Piqué C, Sanmartín-Novell V, Garcia-Navarro X, Expósito-Serrano V, Garnica-Velandia D, Diaz-Sarrió MC, Gómez-Armayones S, Gich Saladich I, Giménez-Arnau A. Melé-Ninot G, et al. Eur J Dermatol. 2022 Sep 1;32(5):629-631. doi: 10.1684/ejd.2022.4334. Eur J Dermatol. 2022. PMID: 36468733 English.
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
Pereyra-Rodríguez JJ, Herranz P, Ruiz-Villaverde R, Elosua-González M, Galán-Gutiérrez M, Figueras-Nart I, Miquel J, de la Cueva P, Serra-Baldrich E, Munera-Campos M, Melé-Ninot G, Expósito-Serrano V, Perez B, Serrano A, Ortiz de Frutos JF, Armario-Hita JC. Pereyra-Rodríguez JJ, et al. Clin Exp Dermatol. 2023 Aug 25;48(9):991-997. doi: 10.1093/ced/llad153. Clin Exp Dermatol. 2023. PMID: 37098171
Sodium metabisulfite a current low relevant allergen in Spain.
Sanz-Sánchez T, Giménez-Arnau AM, Mercader-García P, González Pérez R, Zaragoza-Ninet V, Miquel-Miquel J, Silvestre-Salvador JF, Córdoba-Guijarro S, Carrascosa-Carrillo JM, Gática-Ortega ME, Ruíz-González I, Tous-Romero F, Ortiz-de Frutos FJ, Serra-Baldrich E, Pastor-Nieto A, Rodríguez-Serna M, Sánchez-Pérez J, Sánchez Gilo A, Melé-Ninot G, Sánchez Predreño Guillén P, García-Doval I, Borrego L. Sanz-Sánchez T, et al. Among authors: mele ninot g. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e504-e506. doi: 10.1111/jdv.19702. Epub 2023 Dec 13. J Eur Acad Dermatol Venereol. 2024. PMID: 38088580 No abstract available.
28 results